about
Vaccination with a BCG strain overexpressing Ag85B protects cattle against Mycobacterium bovis challengeExperimental Infection Models of Tuberculosis in Domestic Livestock.Identification of novel Mycobacterium bovis antigens by dissection of crude protein fractions.Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosisSensitivity, specificity, and confounding factors of novel serological tests used for the rapid diagnosis of bovine tuberculosis in farmed red deer (Cervus elaphus)Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis.Immunological approaches to the control of tuberculosis in wildlife reservoirs.Immunobiology of mycobacterial infections in marsupials.Revaccination of cattle with bacille Calmette-Guérin two years after first vaccination when immunity has waned, boosted protection against challenge with Mycobacterium bovis.Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics.Towards more accurate diagnosis of bovine tuberculosis using defined antigens.Vaccination of cattle against Mycobacterium bovis.Control of Mycobacterium bovis infections and the risk to human populations.New skin test for detection of bovine tuberculosis on the basis of antigen-displaying polyester inclusions produced by recombinant Escherichia coli.Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics.Development of vaccines to control bovine tuberculosis in cattle and relationship to vaccine development for other intracellular pathogens.Diverse cytokine profile from mesenteric lymph node cells of cull cows severely affected with Johne's disease.Epidemiology and control of Mycobacterium bovis infection in brushtail possums (Trichosurus vulpecula), the primary wildlife host of bovine tuberculosis in New Zealand.Development and evaluation of an enzyme-linked immunosorbent assay for use in the detection of bovine tuberculosis in cattleProduction of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.Cattle as a model for development of vaccines against human tuberculosis.Epidemiology, diagnostics, and management of tuberculosis in domestic cattle and deer in New Zealand in the face of a wildlife reservoir.Sex difference in the survival rate of wild brushtail possums (Trichosurus vulpecula) experimentally challenged with bovine tuberculosis.Field Trial of an Aerially-Distributed Tuberculosis Vaccine in a Low-Density Wildlife Population of Brushtail Possums (Trichosurus vulpecula)Enhancement of the sensitivity of the whole-blood gamma interferon assay for diagnosis of Mycobacterium bovis infections in cattle.Progress in the development of tuberculosis vaccines for cattle and wildlife.Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle.Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone.Evaluation of a commercial enzyme-linked immunosorbent assay for the diagnosis of bovine tuberculosis from milk samples from dairy cowsBacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents.Vaccines against bovine mastitis in the New Zealand context: what is the best way forward?Advances in ante-mortem diagnosis of tuberculosis in cattle.Engineering mycobacteria for the production of self-assembling biopolyesters displaying mycobacterial antigens for use as tuberculosis vaccine.Bovine tuberculosis: effect of the tuberculin skin test on in vitro interferon gamma responses.Update on vaccination of cattle and wildlife populations against tuberculosis.Bovine tuberculosis vaccine research: historical perspectives and recent advances.Progress in the development of vaccines against rumen methanogens.Overview of vaccination trials for control of tuberculosis in cattle, wildlife and humans.
P50
Q27331427-D6531C21-997E-4920-92AD-F12AB289CBEAQ30393994-B9F971CA-A7A8-4C86-A05E-8F915F291E6AQ33488461-3C03CBCB-3470-443D-82FB-B508B1AEC194Q33592353-4ADE2D85-BBC6-4EDA-8233-104840E4F6AAQ33768661-0A605AAD-CA8B-44DF-A9EA-F9CF94C25B85Q33788201-81609439-0C22-4310-9844-4CD0DA5F279BQ33883504-32FE1576-E999-41EB-9F8D-6AC6F613AB7BQ33889039-45E65C81-566E-4E90-8DFA-8A47A5A9C42FQ33900759-C41EF02D-36E7-4FAD-8EA6-C7CF432359ADQ34122572-094A7D89-131F-4B17-9289-394F222094DAQ34257884-988B1ECD-8B54-4A36-9944-A46DF2047542Q34313617-CA1AAC1A-75A2-4FED-812B-1F1E1FCCE007Q34313644-77044605-9D98-4DCD-861B-650084BE7AC4Q34587098-589DE5A5-EA0D-4C69-9A78-99FD4F5884E2Q35095115-76690FB8-CA6D-44DA-93A7-A556F6C0EF25Q35132033-E0C2B754-4607-4C52-A4AB-AAC36C264472Q35143282-814E31BE-4456-460E-9D26-9502DAFF2A21Q35191190-32479815-7D10-47DB-8D13-FFBF565B7AD1Q35309363-4886D113-608B-4AF7-8BB7-1BF2D4E414F0Q35530302-7AB338E3-63E1-41C2-8AB2-5E1B70ECB3DDQ35599219-017F2327-A6AF-4F91-B1AA-115D803A610BQ35801915-019F8220-B2E5-4B36-A7E5-A949BF2661C1Q36027515-E36A7966-18C8-4301-818C-23289959115AQ36051291-C38189AA-E2FB-42DB-95EE-FB7D2557EEA1Q36090505-1D6D58EE-9FEE-4A74-98BA-8CF22DA8D2B7Q36205576-1A6CAA59-A4EF-4BC2-91D1-7FB96AD73665Q36313607-01762AA3-233A-42A3-A58B-D337079D3B16Q36330400-170C6245-ACB4-4C7F-AE17-A64A8FDBFA2CQ36402053-CECB2CAC-C4F2-4FF1-8974-888EC3A48E78Q36672533-F354F090-E114-45FE-9671-C85069759605Q37469346-1CC27F58-61EF-46A4-93FA-268A6935A08EQ37477387-8A6E7375-B86B-40E3-8381-3A660DE719A0Q37517207-237A30D6-610A-4514-8C5B-6202714071D9Q37569587-903B0C1E-EA3E-4937-A31E-95192E661337Q37644063-D5CC0552-177D-4418-BC70-D34BA686BD16Q37706703-17FFD3EB-0CB8-40F5-877D-7EAE82E8CCD9Q37855175-E66266A6-BE5D-4513-B141-B1EE59A056F2Q37985287-D82C44E2-59BB-448E-B181-4BF0CB90FE21Q38112279-7DD9CEEA-60AF-495F-94B9-ED719B7C1DDAQ38156497-D42C3C6F-826D-4513-AAE4-7A3CF77A3CC3
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bryce M Buddle
@es
Bryce M. Buddle
@en
Bryce M. Buddle
@nl
Bryce M. Buddle
@sl
type
label
Bryce M Buddle
@es
Bryce M. Buddle
@en
Bryce M. Buddle
@nl
Bryce M. Buddle
@sl
prefLabel
Bryce M Buddle
@es
Bryce M. Buddle
@en
Bryce M. Buddle
@nl
Bryce M. Buddle
@sl
P106
P1153
7005597000
P21
P31
P496
0000-0001-6197-6689
P569
2000-01-01T00:00:00Z